Topics
Glioblastoma | Treatment | Targeted therapy | Volasertib
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Volasertib
Zarco N, Dovas A, de Araujo Farias V, Nagaiah NKH, Haddock A, Sims
PA, Hambardzumyan D, Meyer CT, Canoll P, Rosenfeld SS, Kenchappa
RS.
Resistance to
spindle inhibitors in glioblastoma
depends on STAT3 and therapy induced
senescence.
iScience.
2024 Nov 5;27(12):111311. doi:
10.1016/j.isci.2024.111311. PMID:
39640583. Laboratory investigation. ˍ